Antibe Therapeutics Inc Completes $2.4 Million Private Placement
December 16, 2016
DeMarco Allan LLP acts for Antibe Therapeutics Inc. in its private placement of units consisting of brokered and non-brokered components, raising gross proceeds of $2.4 million. Each unit was comprised of one common share and one-half of one common share purchase warrant. Each whole warrant entitles the holder to purchase an additional share at a price of $0.22 for two years. Dominick Inc. acted as agent in connection with the brokered offering.